维普中文期刊产品整合服务
31篇 您的检索式:作者名="Peter LS"
    题名 作者 年代 出处 被引量
1Risk factors and natural history of breast cancer in younger Chinese women显示文摘AIM: To investigate the age differences in the risk factors, clinicopathological characteristics and patterns of treatment of female breast cancer patients. METHODS: Seven thousand one hundred and fiftytwo women with primary breast cancer from the Hong Kong Breast Cancer Registry were recruited after receiving patients' consent, they were asked to complete standardized questionnaires which captured their sociodemographic characteristics and risk factors associated with breast cancer development. Among them, clinicopathological data and patterns of treatment were further collected from medical records of 5523 patients with invasive breast cancers. Patients were divided into two groups according to the age at diagnosis: younger(< 40 years old) vs older patients(≥ 40 years old) for subsequent analyses.RESULTS: Analysis on the sociodemographic characteristics and exposure to risk factors were performed on 7152 women with primary breast cancer and the results revealed that younger patients were more likely to have unhealthy lifestyles; these include a lack of exercise(85.4% vs 73.2%, P < 0.001), having high stress in life(46.1% vs 35.5%, P < 0.001), having dairy/meat-rich diets(20.2% vs 12.9%, P < 0.001),having alcohol drinking habit(7.7% vs 5.2%, P = 0.002). Younger patients were also more likely to have hormone-related risk factors including nulliparity(43.3% vs 17.8%, P < 0.001) and an early age at menarche(20.7% vs 13.2%, P < 0.001). Analyses on clinicopathological characteristics and patterns of treatment were performed on 5523 women diagnosed with invasive breast cancer. The invasive tumours in younger patients showed more aggressive pathological features such as having a higher percentage of grade 3 histology(45.7% vs 36.5%, P < 0.001), having a higher proportion of tumours with lymphovascular invasion(39.6% vs 33.2%, P = 0.003), and having multifocal disease(15.7% vs 10.3%, P < 0.001); they received different patterns of treatment than their older counterparts.CONCLUSION: Younger patients in Hong Kong are more likely to encounter risk factors associated with breast cancer development and have more aggressive tumours than their older counterparts.Winnie Yeo Hang-Mei Lee Amy Chan Emily YY Chan Miranda CM Chan Keeng-Wai Chan Sharon WW Chan Foon-Yiu Cheung Polly SY Cheung Peter HK Choi Josette SY Chor William WL Foo Wing-Hong Kwan Stephen CK Law Lawrence PK Li Janice WH Tsang Yuk Tung Lorna LS Wong Ting-Ting Wong Chun-Chung Yau Tsz-Kok Yau Benny CY Zee 2014World Journal of Clinical Oncology2014,5,5:4
2Stroke rehabilitation:analysis of repeated Barthel index measures显示文摘Granger CV Dewis LS Peters NC 1979Arch Phys Med Rehabil1979,60,:1
3Percutaneous tibial nerve stimulation for the long-term treatment of overactive bladder:3-year results of the STEP study显示文摘PETERS KM CARRICO DJ WOOLDRIDGE LS 2013J Urol2013,189,6:1
4Creatine feeding increase Glut - 4 expression in rat skeletal musele显示文摘Jeong- Sun J Jill LS Peter JO 2005Amphysiol Endocri nol2005,,288:1
5Stroke rehabilitation:analysis of repeated Barthel index measures显示文摘Granger CV Dewis LS Peters NC 1979Arch Phys Med Rehabil1979,60,:1
6Managing discontinuous innovation显示文摘RICE MP COLARELLI O'CONNOR G PETERS LS MORONE JG 1998Research Technology Management1998,41,3:1
7Percutaneous tibial nerve stimulation for the longterm treatment of overac- tive bladder: 3-year results of the STEP study 显示文摘Peters KM Carrico D J Wooldridge LS 2013J Urology2013,189,6:1
8Stroke rehabilitation: analysis of repeated Barthel index measures显示文摘Granger CV Dewis LS Peters NC 1979Arch Phys Med Rehabil1979,60,1:1
9Randomized trial of- percutaneous tibial nerve stimulation versus extended-release toherodine: results from the overactive bladder innovative therapy trial 显示文摘Peters KM Macdiarmid SA Wool- dridge LS 2009J Urol2009,182,3:1
10Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis显示文摘Ludger Sch?ls Peter Bauer Thorsten Schmidt Thorsten Schulte Olaf Riess 2004Lancet Neurology2004,,5:1
11The children's eating behavior inventory:reliability and validity results显示文摘Lynda AA Peter LR David LS 1991Journal of Pediatric Psychology1991,16,5:1
12Stroke rehabi-litation:analysis of repeated Barthel index measures显示文摘Granger CV Dewis LS Peters NC 1979Arch Phys Med Rehabil1979,60,1:1
13Ran- stimulation versus extended-release toherodine:results from the Over- active Bladder Innovative Therapy(OrBIT) Trial显示文摘Peters KM MacDiarmid SA Wooldridge LS domized trial of percutaneous tibial nerve 2009J Urol2009,,182:1
14Innate Immune Respon- ses Are Increased in Chronic Obstructive Pulmonary Disease 显示文摘Katherine JB Jodie LS Peter GG 2011Incrs Inn Inmn Resps in COPD2011,6,3:1
15SCA3: Neurological features, pathogenesis and animal models显示文摘Olaf Riess Udo Rüb Annalisa Pastore Peter Bauer Ludger Sch?ls 2008The Cerebellum2008,,2:1
16Karyotypic analysis predicts outcome of preremission: a Southwest Oncology Group/Eastern Cooperative Oncology Group study 显示文摘F Manilyn LS Kenneth JK Peter AC 2000Blood2000,96,:1
17Randomized trial of percutaneous tibial nerve stimulation versus extended-release tolterodine:results From the overactive bladder innovative therapy trial显示文摘Peters KM Macdiarmid SA Wooldridge LS 2009Journal of Urology2009,182,3:1
18High spontaneous IL-18 production in unrelated marrow transplant recipients is associated with fe- wer transplant-related complications and early deaths 显示文摘Baker ]LS Ronearolo KG Peters C 1999J Bone Marrow Transplant1999,23,3:1
19Determinants of outcomes of sinus surgery : a multi-institutional prospective co- hort study 显示文摘Timolthy LS Jaminie RL Peter HH 2010Otolaryngol Head Neck Surg2010,142,1:1
20Randomized trial of pereutaneous tlbial nerve stimulation versus extended-re- lease tolterodine: resuhs from the overactive bladder innovative therapy trial 显示文摘Peters KM MacDiarmid SA Wooldridge LS 2009J Urol2009,182,:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费